VEGFA and liver disorder: Because of these changes, an increase in splanchnic blood flow occurs, and there is an increased release of vascular endothelial growth factor (VEGF), nitric oxide, and other splanchnic vasodilators, resulting in the worsening of portal hypertension [3].